Drachman Jonathan G insider trades
Drachman Jonathan G has filed 8 Form 4s with the SEC that we hold, for HARP (Director), Neurogene Inc. (NLTX) (President and CEO, Director) and CALA (Director). Across all of them we count 3 purchases worth $944.2K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 100,000 shares of Neurogene Inc. worth $611.0K, dated 2021-08-24. The first filing on our record is dated 2021-08-05 and the latest 2024-03-11.
HARP
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Neurogene Inc. (NLTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-24 | P, purchase reported on Form 4 | 100,000 | $611.0K | 2021-08-26 |
| 2021-08-25 | P, purchase reported on Form 4 | 25,000 | $161.2K | 2021-08-26 |
CALA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-10 | P, purchase reported on Form 4 | 200,000 | $172.0K | 2021-11-10 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1588467) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms